RENAPE and BIG RENAPE Scientific Day

20 April 2024
Come and visit us at the BIG RENAPE Convention on Friday 19 June 2024!

Every year, the GAMIDA team takes part in the RENAPE and BIG RENAPE scientific day, which brings together visceral surgeons, medical oncologists, anatomopathologists, radiologists and researchers interested in primary and metastatic peritoneal diseases.

The BIG RENAPE Convention is organised by the Centre National de référence des tumeurs rares du péritoine (National Reference Centre for Rare Peritoneal Tumours) (RENAPE) and by BIG RENAPE, the clinical-biological database for peritoneal carcinoses of digestive origin, to facilitate exchanges between specialist manufacturers and experts in peritoneal diseases.

This day is an opportunity for our team to meet you and discuss our product developments for intraperitoneal chemotherapy, such as the SunChip2 and CapnoPen® medical devices.

 

What is the SunChip 2?

 

The SunChip2 equipment is a system dedicated to Hyperthermic Intraperitoneal and Intrathoracic Chemotherapy that combines performance, safety, versatility and precision. Used for open and closed chemotherapy techniques and for multiple indications such as abdominal, thoracic or gynaecological, the SunChip2 system is ideal for warming sterile solutions.

Legal information: SunChip 2 Intra-Peritoneal and Intrathoracic Hyperthermic Chemotherapy System.Class IIb medical device. CE0051. Certification body: IMQ.Manufactured by GamidaTECH. Not included in the list of reimbursable products and services provided for in Article L165-1 of the French Social Security Code.Find out more about SunChip2

 

 

What is CapnoPen®?

This day will also be an opportunity for our team to present the CapnoPen® medical device manufactured by CapnoPharm. The CapnoPen® device is the only PIPAC® nebuliser with CE certification for the aerosolization of chemotherapy, DNA, RNA, nanomolecules, viruses and immunotherapy into body cavities. Suitable for a PIPAC® procedure, the CapnoPen® offers optimised driving pressure, diffusion angle and droplet size.

Legal information: CapnoPen®: PIPAC® nebuliser certified for aerosolization of chemotherapy, DNA, RNA, nanomolecules, viruses and immunotherapy in body cavities. Class IIb medical device. CE2696. Certification body: UDEM. Manufactured by CapnoPharm GmbH. Not included in the list of reimbursable products and services provided for in article L165-1 of the French Social Security Code. Read the instructions carefully before use.Find out more about CapnoPen®

 

19 June 2024
Espace Part-Dieu, Immeuble Terra Mundi
2 place de Francfort – 69003 LYON

For all Gamida events, visit our News section.